National SURVIVE study to proceed in patients with glioblastoma following interim analysis BUFFALO, N.Y., May 9, 2025 /PRNewswire-PRWeb/ -- Roswell Park Comprehensive Cancer Center today announced that the ongoing phase 2B SURVIVE clinical trial of SurVaxM in glioblastoma will continue...
↧